CLINICAL ROLE -
Multiple Myeloma Therapy Often Causes Cardiovascular Complications
Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.
Explore Novel Treatment Modalities for Mantle Cell Lymphoma
Two recent clinical trials highlight the novel therapy options available to patients in the upfront and relapsed settings.
HSSP Leads to High Rate of Acid Suppression Therapy Substitution
This study highlights one benefit of the integrated health system specialty pharmacy model for patients who are prescribed acalabrutinib.
An Overview of the Expanding Treatment Landscape of Chronic Myeloid Leukemia
Asciminib offers a new option for patients harboring the T315I mutation.
Treatment Landscape Is Quickly Evolving for CLL/SLL
Patients now have multiple options, including continuous therapy with BTK inhibitors and fixed-duration therapy with venetoclax-based regimens.
2 Commerce Drive Cranbury, NJ 08512